tiprankstipranks
Harrow Health Inc (HROW)
NASDAQ:HROW
US Market
HROW
Harrow Health
RESEARCH TOOLSreports
Want to see HROW full AI Analyst Report?

Harrow Health (HROW) Ratios

624 Followers

Harrow Health Ratios

HROW's free cash flow for Q2 2026 was $0.71. For the 2026 fiscal year, HROW's free cash flow was decreased by $ and operating cash flow was $-0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.24 2.20 2.08 2.82 6.35
Quick Ratio
 2.08 2.06 1.96 2.60 6.00
Cash Ratio
 0.82 0.76 0.52 1.50 5.17
Solvency Ratio
 -0.06 0.04 -0.01 -0.05 -0.09
Operating Cash Flow Ratio
 0.06 0.46 -0.24 0.08 0.09
Short-Term Operating Cash Flow Coverage
 0.00 49.45 0.00 4.76 0.00
Net Current Asset Value
$ -172.66M$ -135.64M$ -130.02M$ -102.68M$ -11.88M
Leverage Ratios
Debt-to-Assets Ratio
 0.72 0.63 0.59 0.61 0.71
Debt-to-Equity Ratio
 19.79 4.80 3.29 2.71 4.07
Debt-to-Capital Ratio
 0.95 0.83 0.77 0.73 0.80
Long-Term Debt-to-Capital Ratio
 0.95 0.82 0.76 0.72 0.79
Financial Leverage Ratio
 27.42 7.62 5.58 4.43 5.70
Debt Service Coverage Ratio
 0.03 1.51 0.96 0.51 0.65
Interest Coverage Ratio
 0.25 1.60 0.39 0.02 0.26
Debt to Market Cap
 0.23 0.14 0.18 0.50 0.26
Interest Debt Per Share
 8.67 7.51 7.06 6.49 4.35
Net Debt to EBITDA
 48.37 4.33 8.21 9.74 3.36
Profitability Margins
Gross Profit Margin
73.28%75.05%75.33%69.55%71.35%
EBIT Margin
-3.79%8.25%4.55%0.62%2.17%
EBITDA Margin
1.63%15.19%11.08%9.18%5.36%
Operating Profit Margin
2.07%14.18%4.42%0.33%2.17%
Pretax Profit Margin
-12.13%-0.63%-8.68%-18.21%-15.81%
Net Profit Margin
-13.51%-1.89%-8.76%-18.75%-15.90%
Continuous Operations Profit Margin
-13.51%-1.89%-8.76%-18.75%-15.90%
Net Income Per EBT
111.36%298.09%100.93%102.96%100.54%
EBT Per EBIT
-586.39%-4.47%-196.33%-5501.16%-730.12%
Return on Assets (ROA)
-8.93%-1.29%-4.49%-7.83%-8.95%
Return on Equity (ROE)
-103.86%-9.80%-25.10%-34.70%-51.05%
Return on Capital Employed (ROCE)
1.81%12.73%2.96%0.16%1.38%
Return on Invested Capital (ROIC)
1.81%12.70%2.96%0.16%1.38%
Return on Tangible Assets
-15.53%-2.29%-8.66%-16.11%-10.74%
Earnings Yield
-2.93%-0.29%-1.46%-6.68%-3.48%
Efficiency Ratios
Receivables Turnover
 2.32 2.46 1.71 3.57 13.87
Payables Turnover
 2.16 1.92 1.27 1.85 3.94
Inventory Turnover
 4.35 5.02 4.60 3.65 3.88
Fixed Asset Turnover
 26.62 24.66 16.24 10.46 8.05
Asset Turnover
 0.66 0.68 0.51 0.42 0.56
Working Capital Turnover Ratio
 2.10 2.55 2.12 1.38 1.18
Cash Conversion Cycle
 72.00 31.35 5.23 5.09 27.77
Days of Sales Outstanding
 157.02 148.65 213.21 102.30 26.32
Days of Inventory Outstanding
 83.82 72.66 79.32 100.06 94.06
Days of Payables Outstanding
 168.84 189.96 287.30 197.27 92.61
Operating Cycle
 240.84 221.30 292.53 202.36 120.38
Cash Flow Ratios
Operating Cash Flow Per Share
 0.17 1.19 -0.62 0.12 0.06
Free Cash Flow Per Share
 0.15 1.16 -1.71 -4.56 -0.22
CapEx Per Share
 0.02 0.03 1.08 4.68 0.28
Free Cash Flow to Operating Cash Flow
 0.91 0.97 2.74 -38.73 -3.56
Dividend Paid and CapEx Coverage Ratio
 11.05 39.80 -0.57 0.03 0.22
Capital Expenditure Coverage Ratio
 11.05 39.80 -0.57 0.03 0.22
Operating Cash Flow Coverage Ratio
 0.02 0.17 -0.10 0.02 0.02
Operating Cash Flow to Sales Ratio
 0.02 0.16 -0.11 0.03 0.02
Free Cash Flow Yield
0.45%2.37%-5.09%-40.71%-1.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -34.33 -350.00 -68.47 -14.96 -28.77
Price-to-Sales (P/S) Ratio
 4.61 6.61 5.99 2.81 4.58
Price-to-Book (P/B) Ratio
 83.72 34.35 17.17 5.19 14.69
Price-to-Free Cash Flow (P/FCF) Ratio
 223.35 42.12 -19.65 -2.46 -66.80
Price-to-Operating Cash Flow Ratio
 203.54 41.06 -53.87 95.13 237.73
Price-to-Earnings Growth (PEG) Ratio
 0.63 4.90 1.98 -0.32 1.10
Price-to-Fair Value
 83.72 34.35 17.17 5.19 14.69
Enterprise Value Multiple
 331.66 47.88 62.26 40.32 88.69
Enterprise Value
 1.49B 1.98B 1.38B 481.72M 421.28M
EV to EBITDA
 331.66 47.88 62.26 40.32 88.69
EV to Sales
 5.39 7.27 6.90 3.70 4.76
EV to Free Cash Flow
 261.49 46.31 -22.63 -3.24 -69.43
EV to Operating Cash Flow
 237.81 45.15 -62.05 125.45 247.09
Tangible Book Value Per Share
 -4.35 -3.36 -3.30 -2.77 0.04
Shareholders’ Equity Per Share
 0.41 1.43 1.95 2.16 1.00
Tax and Other Ratios
Effective Tax Rate
 -0.11 -1.98 >-0.01 -0.03 >-0.01
Revenue Per Share
 7.38 7.41 5.60 3.99 3.23
Net Income Per Share
 -1.00 -0.14 -0.49 -0.75 -0.51
Tax Burden
 1.11 2.98 1.01 1.03 1.01
Interest Burden
 3.20 -0.08 -1.91 -29.24 -7.30
Research & Development to Revenue
 0.07 0.05 0.06 0.05 0.03
SG&A to Revenue
 0.51 0.56 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.03 0.05 0.09 0.12 0.09
Income Quality
 0.82 -8.54 1.27 -0.16 -0.12
Currency in USD